Stay updated on Pembrolizumab in Renal Cell Carcinoma Adjuvant Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Renal Cell Carcinoma Adjuvant Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Renal Cell Carcinoma Adjuvant Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    Adds the NIH grant/contract year 2016 and updates the document revision to v3.6.6 in the study record.
    Difference
    0.0%
    Check dated 2026-08-29T18:35:46.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    No Change Detected
  5. Check
    34 days ago
    Change Detected
    Summary
    A new 'Revision: v3.6.5' label was added; the 'Plain Language Summary' section was removed, and the prior 'Revision: v3.6.4' reference was removed.
    Difference
    0.0%
    Check dated 2026-08-08T09:37:37.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    The page’s revision has been updated from v3.6.3 to v3.6.4, indicating a minor metadata update to the page. This does not correspond to changes in study information or functionality but reflects an updated documentation version.
    Difference
    0.0%
    Check dated 2026-07-25T01:03:13.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    Page revision updated to v3.6.3, signaling a new build of the page. This change does not modify the study details or other user-facing content.
    Difference
    0.0%
    Check dated 2026-07-03T13:34:45.000Z thumbnail image
  8. Check
    77 days ago
    Change Detected
    Summary
    The page’s revision tag was updated from v3.6.0 to v3.6.2, indicating a version update. This change updates metadata without altering study information or user-facing functionality.
    Difference
    0.0%
    Check dated 2026-06-26T10:25:28.000Z thumbnail image
  9. Check
    92 days ago
    Change Detected
    Summary
    Adds a recruitment status note No longer looking for participants and introduces new Help/Navigation sections (How to Read a Study Record, Common Questions, How to Join a Study); also updates the Intervention/Treatment header formatting.
    Difference
    0.1%
    Check dated 2026-06-11T22:49:53.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Renal Cell Carcinoma Adjuvant Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Renal Cell Carcinoma Adjuvant Clinical Trial page.